A detailed history of Davis Rea Ltd. transactions in Zoetis Inc. stock. As of the latest transaction made, Davis Rea Ltd. holds 45,682 shares of ZTS stock, worth $5.43 Million. This represents 1.65% of its overall portfolio holdings.

Number of Shares
45,682
Previous 41,239 10.77%
Holding current value
$5.43 Million
Previous $6.43 Million 3.93%
% of portfolio
1.65%
Previous 1.65%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025

BUY
$141.13 - $159.19 $627,040 - $707,281
4,443 Added 10.77%
45,682 $6.68 Million
Q2 2025

Jul 24, 2025

BUY
$144.41 - $170.3 $2.93 Million - $3.45 Million
20,268 Added 96.65%
41,239 $6.43 Million
Q1 2025

May 06, 2025

BUY
$156.48 - $175.67 $3.28 Million - $3.68 Million
20,971 New
20,971 $3.45 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $55.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Davis Rea Ltd. Portfolio

Follow Davis Rea Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Rea Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davis Rea Ltd. with notifications on news.